Oct 28, 2022
356:303
For every 303 shares held, investors received 356. The price per share adjusted from $0.12 to $0.10.
The split itself did not change the total investment value.
Sprint Bioscience AB (GETTEX:5JA1) operates in the Pharmaceuticals: major industry.
Sprint Bioscience AB company overviewSprint Bioscience AB's most recent stock split was on October 28, 2022. It was a 356-for-303 forward split, so shareholders received 356 shares for every 303 they held.
Sprint Bioscience AB (GETTEX:5JA1) has split its stock 2 times: a 21-for-20 split on August 12, 2021 and a 356-for-303 split on October 28, 2022.
Sprint Bioscience AB has split its stock 2 times. This history records 2 forward splits between August 12, 2021 and October 28, 2022.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Sprint Bioscience AB's 356-for-303 split on October 28, 2022, every 303 shares became 356 shares.
Sprint Bioscience AB has not announced a new split in our records. Its most recent split was on October 28, 2022, 4 years ago. Companies announce splits in advance, and any new GETTEX:5JA1 split will appear on this page.
Already premium?